Evidence map›Paper›PMID 28695089›Full record

ArticlePublic health action2017

Diabetes and pre-diabetes in tuberculosis patients in western Kenya using point-of-care glycated haemoglobin.

P Owiti, A Keter, A D Harries, S Pastakia, C Wambugu, N Kirui, G Kasera, R Momanyi, E Masini, F Some and 1 more

Abstract read
In one paragraph

Article in Public health action, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Clinical, laboratory, and radiographic aspects of patients with pulmonary tuberculosis and dysglycemia and tuberculosis treatment outcomes.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2022
    Article
  15. Review
  16. Article
  17. Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

P OwitiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
A KeterAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
A D HarriesInternational Union Against Tuberculosis and Lung Disease, Paris, France.
S PastakiaPurdue University College of Pharmacy, West Lafayette, Indiana, USA.
C WambuguMinistry of Health, Nairobi, Kenya.
N KiruiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
G KaseraMinistry of Health, Nairobi, Kenya.
R MomanyiMoi Teaching and Referral Hospital, Eldoret, Kenya.
E MasiniMinistry of Health, Nairobi, Kenya.
F SomeAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
A GardnerAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Funding

Enhancing Training for Implementation Research in Chronic Diseases: CITE/KENYAD43TW009105 · FIC · INDIANA UNIVERSITY INDIANAPOLIS · PI AYUO, PAUL OTIENO, LITZELMAN, DEBRA K · 2012 to 2015
$839k
FIC NIH HHS D43 TW009105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DCA VantageHbA1coperational researchprevalence

Identifiers

PMID28695089
PMCPMC5493097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.